• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保肾手术与根治性肾切除术治疗非综合征性单侧肾母细胞瘤的肾功能结局比较。

A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.

机构信息

Division of Pediatric Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Division of Urologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Division of Urology, University of Colorado School of Medicine and the Children's Hospital Colorado, Aurora, CO.

Department of Pediatric Surgery and Urology, Silesian Piasts University of Medicine, Wroclaw, Poland.

出版信息

Urology. 2014 Jun;83(6):1388-93. doi: 10.1016/j.urology.2014.01.051. Epub 2014 Apr 24.

DOI:10.1016/j.urology.2014.01.051
PMID:24768019
Abstract

OBJECTIVE

To better understand the impact of nephron-sparing surgery (NSS) on renal function in patients with nonsyndromic unilateral Wilms tumor (uWT), a group of such patients treated with NSS were compared with a stage-matched cohort managed with radical nephrectomy (RN). The recommended management of nonsyndromic uWT is RN. However, NSS may decrease the risk of long-term renal disease and associated comorbidities.

MATERIALS AND METHODS

An international, multi-institutional review was conducted of nonsyndromic uWT cases managed with NSS and compared with a stage-matched RN cohort. Data were collected on demographics, oncologic characteristics and outcomes, serum creatinine, and estimated glomerular filtration rate (eGFR) calculated via Schwartz formula.

RESULTS

Fifteen patients who underwent NSS (6 females and 9 males) met study criteria and were diagnosed at a median age of 2.5 years (range, 0.2-8.2 years) and followed for a median of 8.4 years (range, 0.5-31.8 years). The stage-matched RN cohort consisted of 15 patients (8 females and 7 males) diagnosed at a median age of 3.7 years (0.3-7.4) and followed for a median of 2.1 years (0.6-10.5 years). The median preoperative eGFR was 91.7 (39.4-237.7) and 149.9 (93.8-215.9) for NSS and RN, respectively, P=.026. The median eGFR at last follow-up was 135.3 (57.5-185.8) and 131.0 (98.6-161.2) for NSS and RN, respectively, P=.95. The median change in eGFR during the study period was a gain of 28.6 (-51.9 to 83.0) for the NSS cohort vs a loss of 19.1 (-54.7 to 25.2) for the RN cohort, P=.007.

CONCLUSION

In a highly selected patient population with nonsyndromic uWT, NSS provides excellent renal function preservation when compared with RN. These data require validation via prospective investigation on a larger scale.

摘要

目的

更好地了解保肾手术(NSS)对非综合征单侧肾母细胞瘤(uWT)患者肾功能的影响,将一组接受 NSS 治疗的此类患者与接受根治性肾切除术(RN)治疗的分期匹配队列进行比较。非综合征性 uWT 的推荐治疗方法是 RN。然而,NSS 可能会降低长期肾病和相关合并症的风险。

材料和方法

对接受 NSS 治疗的非综合征性 uWT 病例进行了国际多机构回顾性研究,并与分期匹配的 RN 队列进行了比较。收集了人口统计学、肿瘤学特征和结果、血清肌酐和 Schwartz 公式计算的估算肾小球滤过率(eGFR)数据。

结果

15 名接受 NSS(6 名女性和 9 名男性)的患者符合研究标准,中位年龄为 2.5 岁(范围,0.2-8.2 岁),中位随访时间为 8.4 年(范围,0.5-31.8 年)。分期匹配的 RN 队列由 15 名患者(8 名女性和 7 名男性)组成,中位诊断年龄为 3.7 岁(0.3-7.4 岁),中位随访时间为 2.1 年(0.6-10.5 年)。NSS 和 RN 的术前中位 eGFR 分别为 91.7(39.4-237.7)和 149.9(93.8-215.9),P=.026。NSS 和 RN 的末次随访中位 eGFR 分别为 135.3(57.5-185.8)和 131.0(98.6-161.2),P=.95。NSS 组研究期间 eGFR 的中位变化为增加 28.6(-51.9 至 83.0),而 RN 组为减少 19.1(-54.7 至 25.2),P=.007。

结论

在非综合征性 uWT 的高度选择患者人群中,与 RN 相比,NSS 可提供出色的肾功能保留。这些数据需要通过更大规模的前瞻性研究进行验证。

相似文献

1
A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.保肾手术与根治性肾切除术治疗非综合征性单侧肾母细胞瘤的肾功能结局比较。
Urology. 2014 Jun;83(6):1388-93. doi: 10.1016/j.urology.2014.01.051. Epub 2014 Apr 24.
2
Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience.单侧肾母细胞瘤(UWT)的保留肾单位手术(NSS):国际小儿肿瘤学会(SIOP)2001年的经验。
Pediatr Blood Cancer. 2014 Dec;61(12):2175-9. doi: 10.1002/pbc.25185. Epub 2014 Aug 23.
3
Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.保肾手术与根治性肾切除术对肾功能的影响:EORTC 随机试验 30904 的结果。
Eur Urol. 2014 Feb;65(2):372-7. doi: 10.1016/j.eururo.2013.06.044. Epub 2013 Jul 2.
4
Repeat nephron-sparing surgery for children with bilateral Wilms tumor.对双侧 Wilms 瘤患儿行重复肾部分切除术。
J Pediatr Surg. 2014 Jan;49(1):149-53. doi: 10.1016/j.jpedsurg.2013.09.048. Epub 2013 Oct 5.
5
[Is nephron-sparing surgery relevant for unilateral Wilms tumors?].[保留肾单位手术对单侧肾母细胞瘤是否适用?]
Arch Pediatr. 2017 Jul;24(7):650-658. doi: 10.1016/j.arcped.2017.04.003. Epub 2017 May 31.
6
Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.保留肾单位手术治疗部分局部晚期肾细胞癌患者的肿瘤学疗效与安全性
BJU Int. 2007 Dec;100(6):1235-9. doi: 10.1111/j.1464-410X.2007.07225.x.
7
Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms tumor.单侧肾母细胞瘤行部分肾切除术与根治性肾切除术的肿瘤学结果比较。
Pediatr Blood Cancer. 2012 Jun;58(6):898-904. doi: 10.1002/pbc.23240. Epub 2011 Jul 9.
8
[Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].对于大于4厘米的肿瘤,保留肾单位手术在保留肾功能结果方面优于根治性肾切除术。
Prog Urol. 2011 Nov;21(12):842-50. doi: 10.1016/j.purol.2011.05.005. Epub 2011 Jul 16.
9
Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm.功能性分析:选择性保肾手术与根治性肾切除术治疗大于 4 厘米的肾肿瘤。
Urology. 2012 Mar;79(3):607-13. doi: 10.1016/j.urology.2011.10.073.
10
Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy.根治性或部分肾切除术后发生慢性肾功能不全、蛋白尿和代谢性酸中毒的发生率及危险因素比较。
BJU Int. 2009 Aug;104(4):476-81. doi: 10.1111/j.1464-410X.2009.08376.x. Epub 2009 Feb 10.

引用本文的文献

1
Efficacy and late kidney effects of nephron-sparing surgery in the management of unilateral Wilms tumor: a systematic review and meta-analysis.保肾手术治疗单侧肾母细胞瘤的疗效及晚期肾脏影响:系统评价和荟萃分析。
Pediatr Surg Int. 2023 Dec 27;40(1):29. doi: 10.1007/s00383-023-05611-x.
2
Surgery in Bilateral Wilms Tumor-A Single-Center Experience.双侧肾母细胞瘤的手术治疗——单中心经验
Children (Basel). 2023 Nov 7;10(11):1790. doi: 10.3390/children10111790.
3
A radiomics nomogram for preoperative prediction of nephron-sparing surgery in patients with bilateral Wilms tumor.
用于术前预测双侧肾母细胞瘤患者保留肾单位手术的影像组学列线图。
Quant Imaging Med Surg. 2023 Jul 1;13(7):4234-4244. doi: 10.21037/qims-22-1129. Epub 2023 May 8.
4
RENAL nephrometry scoring system in bilateral Wilms tumor: predictive application.双侧肾母细胞瘤的肾肿瘤体积测量评分系统:预测应用。
Pediatr Surg Int. 2023 Jul 10;39(1):230. doi: 10.1007/s00383-023-05500-3.
5
Preoperative radiomic signature based on CT images for noninvasive evaluation of localized nephroblastoma in pediatric patients.基于CT图像的术前影像组学特征对小儿局限性肾母细胞瘤的无创评估
Front Oncol. 2023 Apr 20;13:1122210. doi: 10.3389/fonc.2023.1122210. eCollection 2023.
6
Pediatric Small Renal Masses: Can Tumor Size Predict Histology and the Potential for Nephron-sparing Surgery?小儿肾脏小肿块:肿瘤大小能否预测组织学和保留肾单位手术的可能性?
J Urol. 2023 Mar;209(3):582-590. doi: 10.1097/JU.0000000000003092. Epub 2022 Nov 29.
7
Nephron sparing surgery outcomes in Wilms' tumor: is it ready for primetime?保留肾单位手术治疗肾母细胞瘤的疗效:是否已经准备好进入黄金时代?
Pediatr Surg Int. 2022 Nov 28;39(1):5. doi: 10.1007/s00383-022-05299-5.
8
Multidisciplinary Treatment Strategies for Wilms Tumor: Recent Advances, Technical Innovations and Future Directions.肾母细胞瘤的多学科治疗策略:最新进展、技术创新与未来方向
Front Pediatr. 2022 Jul 14;10:852185. doi: 10.3389/fped.2022.852185. eCollection 2022.
9
Nephron-Sparing Surgery in Nonsyndromic Unilateral Wilms' tumor: An Insight into the Ongoing Surgical Controversy.非综合征性单侧肾母细胞瘤的保肾手术:对当前手术争议的洞察
J Indian Assoc Pediatr Surg. 2022 Jan-Feb;27(1):13-24. doi: 10.4103/jiaps.jiaps_205_21. Epub 2022 Jan 11.
10
Kidney injury rates after unilateral nephrectomy in childhood-a systematic review and meta-analysis.儿童单侧肾切除术后的肾损伤发生率:系统评价和荟萃分析。
Nephrol Dial Transplant. 2022 Nov 23;37(12):2457-2473. doi: 10.1093/ndt/gfac021.